525 related articles for article (PubMed ID: 11434451)
21. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of pain in cancer with systemically administered opioids].
Enting RH; van der Rijt CC; Wilms EB; Lieverse PJ; de Wit R; Smitt PA
Ned Tijdschr Geneeskd; 2001 May; 145(20):950-4. PubMed ID: 11396259
[TBL] [Abstract][Full Text] [Related]
23. Methadone: an effective alternative to morphine for pain relief in cancer patients.
Shelton BW; Deynes-Romero J; Tofani-Montalvo M; RamÃrez-Rivera J; Jaumne-Anselmi F
Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708
[TBL] [Abstract][Full Text] [Related]
24. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
[TBL] [Abstract][Full Text] [Related]
25. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
[TBL] [Abstract][Full Text] [Related]
26. The role of methadone in cancer pain treatment--a review.
Leppert W
Int J Clin Pract; 2009 Jul; 63(7):1095-109. PubMed ID: 19570126
[TBL] [Abstract][Full Text] [Related]
27. Management of chronic neuropathic pain with methadone: a review of 13 cases.
Altier N; Dion D; Boulanger A; Choinière M
Clin J Pain; 2005; 21(4):364-9. PubMed ID: 15951657
[TBL] [Abstract][Full Text] [Related]
28. Successful use of oral methadone after failure of intravenous morphine and ketamine.
Sartain JB; Mitchell SJ
Anaesth Intensive Care; 2002 Aug; 30(4):487-9. PubMed ID: 12180591
[TBL] [Abstract][Full Text] [Related]
29. Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review.
Mercadante S; Bruera E
J Pain Symptom Manage; 2018 Mar; 55(3):998-1003. PubMed ID: 29101087
[TBL] [Abstract][Full Text] [Related]
30. Prescribing methadone, a unique analgesic.
Manfredi PL; Houde RW
J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
[No Abstract] [Full Text] [Related]
31. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
Binhas M; Krakowski I; Marty J
Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755
[TBL] [Abstract][Full Text] [Related]
32. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
33. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
34. Pain management.
Ripamonti CI
Ann Oncol; 2012 Sep; 23 Suppl 10():x294-301. PubMed ID: 22987980
[TBL] [Abstract][Full Text] [Related]
35. Differences in the ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic pain.
Gagnon B; Bruera E
J Pain Symptom Manage; 1999 Aug; 18(2):120-5. PubMed ID: 10484859
[TBL] [Abstract][Full Text] [Related]
36. Methadone titration in opioid-resistant cancer pain.
Scholes CF; Gonty N; Trotman IF
Eur J Cancer Care (Engl); 1999 Mar; 8(1):26-9. PubMed ID: 10362950
[TBL] [Abstract][Full Text] [Related]
37. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal therapy for chronic pain.
Miles J
Stereotact Funct Neurosurg; 2001; 77(1-4):156-8. PubMed ID: 12378067
[TBL] [Abstract][Full Text] [Related]
39. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
[TBL] [Abstract][Full Text] [Related]
40. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
